AMP-303 and AMP-601 are new hair loss treatments targeting dermalpapillacells, with AMP-303 showing early efficacy in transitioning vellus hairs to terminal hairs after one injection. Further clinical trials are planned, and these treatments are seen as promising due to their biologic approach and less frequent application compared to daily treatments.
A study that outlines the full model for androgenic alopecia (AGA) which links DHT to cellular senescence in dermalpapillacells, and suggests black chokeberry as a source of cyanidin 3-O-arabinoside polyphenol with potential anti-oxidant properties that could reverse this process. The post encourages reaching out to experts in anti-aging and longevity to research treatments involving the polyphenol.
The conversation is about using vitamin C and Magnesium L-Threonate for hair growth by reducing DHT binding to dermalpapillacells. The original post about vitamin C's pH levels and sebum control was possibly removed by a moderator.
A new hair loss treatment using dermal exosomes can restore up to 90% of lost hair in mice. Users discuss potential human trials and compare it to Minoxidil and Finasteride.
A potential non-invasive topical treatment targeting the WNT Signaling Pathway for hair regeneration is being researched, with positive results on human hair follicle cells. Current effective treatments for hair loss include Minoxidil, finasteride, and hair transplantation.